New Zealand markets open in 2 hours 43 minutes

Jiangsu CoWin Biotech Co., Ltd. (688426.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
18.66+0.60 (+3.32%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
123,201
171,341
521,600
338,463
233,212
Cost of revenue
49,935
60,615
156,957
93,632
53,246
Gross profit
73,266
110,726
364,644
244,831
179,965
Operating expenses
Research development
91,521
88,260
74,016
38,583
23,759
Selling general and administrative
100,753
97,499
77,575
54,884
31,803
Total operating expenses
222,075
215,977
169,567
103,213
54,868
Operating income or loss
-148,809
-105,251
195,076
141,619
125,098
Interest expense
-
1,695
1,930
1,918
116.62
Income before tax
-140,550
-92,983
195,398
144,529
126,440
Income tax expense
-17,573
-9,239
24,825
18,681
18,283
Income from continuing operations
-122,977
-83,744
170,573
125,847
108,157
Net income
-117,366
-84,409
159,259
125,847
108,157
Net income available to common shareholders
-117,366
-84,409
159,259
125,847
108,157
Basic EPS
-0.64
-0.75
1.72
1.50
1.54
Diluted EPS
-0.65
-0.75
1.72
1.49
1.54
Basic average shares
110,156
112,247
92,485
83,898
70,156
Diluted average shares
112,683
112,847
92,862
84,367
70,156